EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Usefulness of Additional ECG Indicators for Prognosis Prediction in Patients With Cardiac Sarcoidosis

Junichi Kamoshida, Kohei Ishibashi, Takanori Kawabata, Kei Enokizono, Satoshi Oka, Yuichiro Miyazaki, Keiko Shimamoto, Akinori Wakamiya, Nobuhiko Ueda, Kenzaburo Nakajima, Tsukasa Kamakura, Mitsuru Wada und 5 weitere

JACC: Clinical Electrophysiology · 2025-11 · 11 (11) · 2365-2375

DOI: 10.1016/j.jacep.2025.07.008 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2025-11. Verfasst von Junichi Kamoshida und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Centre, Suita, Japan; Department of Cardiology, Tokyo Medical University,…. Hauptthemen laut MEDLINE: Cardiomyopathies, Electrocardiography, Sarcoidosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiac sarcoidosis (CS) is characterized by variability in ventricular repolarization and depolarization due to sarcoid granulomas. The T-wave peak to end (Tp-e)/QT ratio and fragmented QRS complex (fQRS), which are markers of repolarization dispersion and depolarization abnormality, respectively, predict arrhythmic risk in cardiac conditions. However, their prognostic value in CS remains uncertain. OBJECTIVES: This study aimed to assess the association between the Tp-e/QT ratio and fQRS presence with prognosis and arrhythmic risk in CS patients through a Japanese nationwide survey. METHODS: This multicenter retrospective cohort study used data from a nationwide survey on CS conducted from 2014 to 2016 in Japan. The authors categorized CS patients based on Tp-e/QT ratios and fQRS presence. They assessed a composite of all-cause mortality and ventricular arrhythmia events as primary outcomes, and a composite of cardiac-related deaths (heart failure and sudden death) and ventricular arrhythmia events as secondary outcomes. RESULTS: Among 227 CS patients (151 women, median follow-up: 1,286 days), grouped by Tp-e/QT ratios (cutoff value: 0.232) and fQRS presence, higher Tp-e/QT ratios and fQRS indicated poorer prognosis. Multivariable analysis revealed high Tp-e/QT (HR: 3.01; P = 0.002), fQRS (HR: 2.48; P = 0.012), past ventricular tachycardia, and left ventricular ejection fraction (LVEF) ≤35% as independent adverse outcome predictors. These electrocardiograph indicators were also significant in CS patients with LVEF >35% (Tp-e/QT > 0.232: HR: 3.62; P = 0.011; fQRS: HR: 3.38; P = 0.022). CONCLUSIONS: High Tp-e/QT ratios and fQRS presence in CS patients suggest worse prognosis, particularly with LVEF >35%, highlighting their importance in early-stage arrhythmic risk. (Investigation of Fixation Behavior During Perimetry Test; UMIN000018393).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesElectrocardiographySarcoidosisAdultAgedFemaleHumansMaleMiddle AgedArrhythmias, CardiacJapanPrognosisRetrospective Studies

Stichwörter der Autor:innen

ECG indicatorscardiac sarcoidosisfQRShigh Tp-e/QT ratioprognostic factor

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Centre, Suita, Japan; Department of Cardiology, Tokyo Medical University, Nishi-shinjuku, Tokyo, Japan.
  • Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Centre, Suita, Japan.
  • Department of Data Science, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Centre, Suita, Japan; Department of Cardiology, Yonemori Hospital, Kagoshima, Japan.
  • Department of General Internal Medicine 3, Kawasaki Medical School General Medical Center, Okayama, Japan.
  • Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Centre, Suita, Japan. Electronic address: kusanokengo@ncvc.go.jp.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kamoshida, J., Ishibashi, K., Kawabata, T., Enokizono, K., Oka, S., Miyazaki, Y., Shimamoto, K., Wakamiya, A., Ueda, N., Nakajima, K., Kamakura, T., Wada, M., Inoue, Y., Miyamoto, K., Nagase, S., Aiba, T., & Kusano, K. (2025). Usefulness of Additional ECG Indicators for Prognosis Prediction in Patients With Cardiac Sarcoidosis. JACC: Clinical Electrophysiology, 11(11), 2365-2375. https://doi.org/10.1016/j.jacep.2025.07.008

Vancouver

Kamoshida J, Ishibashi K, Kawabata T, Enokizono K, Oka S, Miyazaki Y, et al. Usefulness of Additional ECG Indicators for Prognosis Prediction in Patients With Cardiac Sarcoidosis. JACC: Clinical Electrophysiology. 2025;11(11):2365-2375. doi:10.1016/j.jacep.2025.07.008

BibTeX
@article{Kamoshida2025,
  author = {Kamoshida, Junichi and Ishibashi, Kohei and Kawabata, Takanori and Enokizono, Kei and Oka, Satoshi and Miyazaki, Yuichiro and Shimamoto, Keiko and Wakamiya, Akinori and Ueda, Nobuhiko and Nakajima, Kenzaburo and Kamakura, Tsukasa and Wada, Mitsuru and Inoue, Yuko and Miyamoto, Koji and Nagase, Satoshi and Aiba, Takeshi and Kusano, Kengo},
  title = {Usefulness of Additional ECG Indicators for Prognosis Prediction in Patients With Cardiac Sarcoidosis},
  journal = {JACC: Clinical Electrophysiology},
  year = {2025},
  volume = {11},
  number = {11},
  pages = {2365--2375},
  doi = {10.1016/j.jacep.2025.07.008}
}
Kostenlos starten →